Immunocompromised populations develop a lower immunogenic response to COVID-19 vaccines, leaving them at a higher risk of severe disease, hospitalization, and death. Patients with HIV who have low ...
July 30, 2010 (Vienna, Austria) — Although initiation of highly active antiretroviral therapy (HAART) against HIV is associated with a lower risk for progression to AIDS, and a lower risk for ...
Our data demonstrates that among patients initiating therapy in RLS with (mainly) an NNRTI-based regimen, CD4 cell count recovery is impaired in the presence of on-going HIV-RNA replication over an 18 ...
Dr Sension underlines the value of CD4 recovery from payer and clinician perspectives. Ryan Haumschild, PharmD, MS, MBA: It’s important that we talk about CD4 recovery and how it’s important to the ...